SKIN

SkinHealth Systems Inc. (SKIN) shares jumped 9% following completion of a 1-for-20 reverse stock split on October 14, 2026, which helped the company regain compliance with Nasdaq's minimum bid price requirement. However, the company faces significant headwinds with expected quarterly losses of $1.35 per share (down 1400% year-over-year) and revenues projected to decline 5% to $67.18 million. With no recent changes in earnings estimate revisions and a Zacks Rank #3 (Hold) rating, analysts question whether the recent rally can sustain.

SkinHealth Systems (Nasdaq: SKIN) announced the European launch of SkinStylus® SteriLock® MicroSystem, a professional micro- and nano-needling device, now available in the UK, Ireland, Germany, France, Spain, and Portugal. The expansion leverages the company's established Hydrafacial distribution network and aims to offer complementary aesthetic solutions to practitioners across the region.

SkinHealth Systems announced the launch of HydraClear Treatment Booster, a triple-acid formula designed to clarify and balance blemish-prone skin. Clinical trials showed a 38% mean reduction in total blemishes after four treatments, with 81% of participants showing fewer visible blemishes. The product will be integrated into Deluxe and Platinum Hydrafacial treatments.

SkinHealth Systems announced the European launch of SkinStylus® SteriLock MicroSystem, a professional microneedling and nanoneedling device, across the UK, Ireland, Germany, France, Spain, and Portugal. The expansion leverages the company's established Hydrafacial® network and represents a strategic move to offer complementary aesthetic solutions beyond its core skincare offerings.

SkinHealth Systems announced the European expansion of its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device, across the UK, Ireland, Germany, France, Spain and Portugal. The company will leverage its established Hydrafacial commercial organization and provider relationships to introduce the complementary technology to aesthetic professionals in the region.

SkinHealth Systems announced the European expansion of its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device, now available in the UK, Ireland, Germany, France, Spain, and Portugal. The company will leverage Hydrafacial's established European distribution network to market the complementary technology to aesthetic professionals, supporting its strategy to build a broader medical aesthetics ecosystem.